Highlight of April 2015

Take a look at this month’s featured report and get exciting trading ideas.


 

April 23, 2015

“Nearly all men can stand adversity, but if you want to test a man’s character, give him power.”
— Abraham Lincoln

  • As each day goes by, I am more confident we will get a running breakout in the S&P 500 (SPY). See chart below.
  • ATRA is now the newest hottest biotech on the board. We will keep the stop nice and wide so we can maximize the upside potential.
  • The sooner ADXS prices their secondary offering the better it should be for the continuation move higher.
  • Names to keep on the radar include: AGEN (cheapie), ST, BLCM, IPGP.

Advaxis (ADXS) long is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology. The Lm-LLO technology, using bioengineered live attenuated Listeria monocytogenes bacteria, is the only known cancer immunotherapy agent shown in preclinical studies to both generate cancer fighting T-cells directed against a cancer antigen and neutralize Tregs and myeloid-derived suppressor cells MDSCs), that protect the tumor…

SUBSCRIBE TO READ MORE

monthly-snapshot2